Cargando…
Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden
BACKGROUND: There are concerns that individuals with chronic immune‐mediated diseases are at increased risk of COVID‐19 and related severe adverse outcome, including intensive care admission or death. We aimed to explore the absolute and relative risk of severe COVID‐19 in inflammatory bowel disease...
Autores principales: | Ludvigsson, Jonas F., Axelrad, Jordan, Halfvarson, Jonas, Khalili, Hamed, Larsson, Emma, Lochhead, Paul, Roelstraete, Bjorn, Simon, Tracey G., Söderling, Jonas, Olén, Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014882/ https://www.ncbi.nlm.nih.gov/pubmed/33704918 http://dx.doi.org/10.1002/ueg2.12049 |
Ejemplares similares
-
Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden
por: Sun, Jiangwei, et al.
Publicado: (2023) -
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study
por: Mårild, Karl, et al.
Publicado: (2022) -
Statin use and risk of colorectal cancer in patients with inflammatory bowel disease
por: Sun, Jiangwei, et al.
Publicado: (2023) -
Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study
por: Ludvigsson, Jonas F, et al.
Publicado: (2022) -
Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study
por: Sun, Jiangwei, et al.
Publicado: (2022)